Pepdox
Studies
Peptides
Calculator
Pioneering oral peptide therapy for patients with type 2 diabetes. | Pepdox
Home
/
Search
/
PMID 31189516
Pioneering oral peptide therapy for patients with type 2 diabetes.
The lancet. Diabetes & endocrinology
2019
PMID: 31189516
View on PubMed
DOI: 10.1016/S2213-8587(19)30182-2
Semaglutide
Authors
Nauck, Michael A; Meier, Juris J